Security key
83006G401
60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SXTP)
CUSIP: 83006G401
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 4,285,676
- Total 13F shares
- 44,358
- Share change
- +1,763
- Total reported value
- $22,547
- Price per share
- $0.51
- Number of holders
- 7
- Value change
- -$23,782
- Number of buys
- 4
- Number of sells
- 2
Report period
Q4 2025
Institutions
7
Top holders
7
SXTP full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
60 DEGREES PHARMACEUTICALS, INC. SEC filings
60 DEGREES PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83006G401
Recent filing periods:
Ownership snapshot
Top shareholders of SXTP - 60 Degrees Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
Lead holder
CVI Investments, Inc.
13D/G signal
CVI Investments, Inc.
Evidence rows
27
Latest as of
15 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 9.9%
13D/G row: CVI Investments, Inc.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
9.9%
|
$670,061
455,545 shares
|
+$187,456 | 30 Sep 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$226,656
77,357 shares
|
$0 | 31 Mar 2025 |
| Orca Capital AG |
13D/G
|
4.9%
|
$382,327
166,229 shares
|
$0 | 15 Jul 2025 |
| Ayrton Capital LLC |
13D/G
|
4.1%
|
$260,977
177,427 shares
|
+$20,515 | 30 Sep 2025 |
| Cheryl Xu |
3/4/5
Director
|
0.37%
|
$45,866
15,816 shares
|
+$14,410 | 03 Jun 2025 |
| DRW Securities, LLC |
13F
Company
|
0.59%
|
$37,312
25,211 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.29%
|
$18,299
12,449 shares
|
— | 30 Sep 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.07%
|
$4,647
3,140 shares
|
— | 30 Sep 2025 |
| CITIGROUP INC |
13F
Company
|
0%
|
$278
189 shares
|
— | 30 Sep 2025 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
0%
|
$141
100 shares
|
— | 30 Sep 2025 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0%
|
$44
30 shares
|
— | 30 Sep 2025 |
| Knight Therapeutics Inc. |
3/4/5
Former 10% Owner
|
—
mixed-class rows
|
$5,475,241
1,232,700 shares
mixed-class rows
|
— | 28 Jul 2023 |
| KENTUCKY TECHNOLOGY INC. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$196,875
525,000 shares
|
— | 11 Jul 2023 |
| Florida State University Research Foundation Inc. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$151,875
405,000 shares
|
— | 11 Jul 2023 |
| Geoffrey S. Dow |
3/4/5
President and CEO, Director
|
—
mixed-class rows
|
$47,837
584,618 shares
mixed-class rows
|
+$19,964 | 15 Dec 2025 |
| Tyrone Miller |
3/4/5
CFO
|
—
mixed-class rows
|
$38,237
101,370 shares
mixed-class rows
|
— | 17 Jan 2025 |
| Kristen Landon |
3/4/5
Chief Operating Officer
|
—
mixed-class rows
|
$11,713
8,707 shares
mixed-class rows
|
— | 17 Jan 2025 |
| Walleye Capital LLC |
13F
Company
|
—
class O/S missing
|
$8,248
222,906 shares
|
— | 30 Sep 2025 |
| Clear Street Group Inc. |
13F
Company
|
—
class O/S missing
|
$5,394
145,787 shares
|
— | 30 Sep 2025 |
| Charles W. Allen |
3/4/5
Director
|
—
mixed-class rows
|
$4,622
18,000 shares
mixed-class rows
|
— | 31 Dec 2023 |
| Paul Field |
3/4/5
Director
|
—
mixed-class rows
|
$4,014
18,000 shares
mixed-class rows
|
— | 31 Dec 2023 |
| Stephen Toovey |
3/4/5
Director
|
—
mixed-class rows
|
$4,014
18,000 shares
mixed-class rows
|
— | 31 Dec 2023 |
| UBS Group AG |
13F
Company
|
—
mixed-class rows
|
$2,214
2,290 shares
mixed-class rows
|
— | 30 Sep 2025 |
| TORNO CAPITAL, LLC |
13F
Company
|
—
class O/S missing
|
$1,745
47,169 shares
|
— | 30 Sep 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$769
20,795 shares
|
— | 30 Sep 2025 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
class O/S missing
|
$642
17,340 shares
|
— | 30 Sep 2025 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
class O/S missing
|
$503
13,586 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
44,358
Rows loaded
7
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
7
Q4 2025 holders
7
Holder diff
0
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.